Dr Sung Min Son and Prof David Rubinsztein (UK DRI at Cambridge) have identified a key enzyme driving forms of Parkinson’s disease, highlighting a promising new target for treatment.
Neurological diseases are the foremost cause of ill health and disability worldwide. Open Access Government offers an overview of the prevalence of these conditions.
Yesterday on World Parkinson's Day in the Journal of Parkinson's Disease, researchers revealed the potential environmental origins of Parkinson's disease.
We spoke with Parkinson’s UK, an organisation dedicated to funding important research and supporting those affected by Parkinson’s, about the prevalence, impact, and management of the condition.
A group of researchers around the globe have created a portable, non-invasive device capable of identifying biomarkers associated with Alzheimer's and Parkinson's disease.
A team of neuroscientists, neurosurgeons and engineers have created a speech prosthesis that can interoperate a person's brain signals and convert them into speech.
In a groundbreaking collaboration, the Accelerated Capability Environment (ACE) has teamed up with the NHS's AI Skunkworks to harness AI to diagnose Parkinsons with unprecedented speed.
Digital health platforms offer vast potential for enhancing the lives of PD patients and caregivers. A study in the Journal of Nutrition Education and Behavior emphasises their role in improving healthcare services.
